middle.news
Artrya Converts First SAPPHIRE Participant Into Five-Year US Customer
8:32am on Friday 2nd of October, 2026 AEST
•
Healthcare Technology
Read Story
Artrya Converts First SAPPHIRE Participant Into Five-Year US Customer
8:32am on Friday 2nd of October, 2026 AEST
Key Points
First SAPPHIRE Study participant converted to a commercial customer
US$0.5 million minimum value from Salix Coronary Anatomy
Deployment spans applicable workflows across a 15-hospital network
Artrya’s US commercial customer base rises to four
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Artrya (ASX:AYA)
OPEN ARTICLE